A designation granted to a medicine intended to treat a rare condition. The medicine must meet specific criteria to be recognized as an orphan drug, thereby making it eligible for incentives such as market exclusivity and protection from competition.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management